ETTLINGEN, Germany, May 28, 2025--Bruker Corporation (Nasdaq: BRKR) today announced the launch of the MOVE-T, a state-of-the-art liquid dairy analyzer designed to elevate quality control standards ...

Bruker Introduces Novel MOVE-T System for Transferable, Robust Milk and Liquid Dairy Analysis with FT-NIR Technology Precision in Every Drop: The New MOVE-T Liquid Dairy Analyzer for Enhanced ...

Bruker and 10x Genomics have agreed to settle a patent dispute relating to products originally developed by Nanostring, a company Bruker acquired in 2024.

Vertex had plans to hire 1,300 employees in Wilmington, but it never even got close.

Vertex Pharmaceuticals missed first-quarter profit and revenue forecasts as costs jumped.

Is Vertex stock a buy? Vertex's share price is still in positive territory year to date despite today's pullback.

Bruker Corporation today announced the launch of the nVista 2P miniature, two-photon microscope, a groundbreaking addition to the Inscopix product line for functional imaging of freely behaving ...

Bruker Announces Majority Acquisition of RECIPE, a Leading Provider of Mass Spectrometry-based Diagnostic Assay Kits for Therapeutic Drug Monitoring ...

Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the twenty-six research firms that are ...

Shares of Bruker Co. (NASDAQ:BRKR – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the eleven brokerages that are presently covering the stock, MarketBeat ...

TD Cowen analyst Dan Brennan lowered the firm’s price target on Bruker (BRKR) to $55 from $70 and keeps a Hold rating on the shares. The firm said management sees little risk even if the budget ...

Bruker targets approximately 140 basis points of non-GAAP operating margin expansion in 2025, driven by operational improvements and integration synergies.